Investor Relations

NYSE: TDOC -0.15 -2.12%
Volume: 29,233
20 minute delay November 14, 2025

Teladoc Health is the global leader in virtual care.

We are transforming how better health happens.

Teladoc Health is delivering and orchestrating care across patients, care providers, platforms, and partners for more complete and personalized care. Through our technology, services and clinical expertise, we equip care teams to perform at their highest caliber and address comprehensive health needs – physical and mental, simple and complex, urgent and ongoing. By applying the power of technology and insights, we elevate care experiences and make moments of care more impactful. We work with health plans, employers, health systems, and partners around the world to unlock access and outcomes at unmatched scale, helping millions of people live their healthiest lives.

Investor Events

Investor News

November 6, 2025
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective November 1, 2025, in connection with commencing employment as Chief Technology Officer, Dave Ross was granted an award of restricted stock units covering 86,906 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 86,906 shares of Common Stock (for which up to 173,812 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The performance stock units provide a target number of shares of Common Stock that would be earned over three years based on various financial metrics. The award was approved by the...
Read More
October 29, 2025
Teladoc Health Reports Third Quarter 2025 Results
NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 (“Third Quarter 2024”). Highlights Third Quarter 2025 revenue of $626.4 million, down 2% year-over-year Third Quarter 2025 net loss of $49.5 million, or $0.28 per share Third Quarter 2025 adjusted EBITDA of $69.9 million, down 16% year-over-year Integrated Care segment revenue of $389.5 million, up 2% year-over-year, and adjusted EBITDA margin of 17.0% BetterHelp segment revenue of $236.9 million, down 8% year-over -year, and adjusted EBITDA margin of 1.6%
“In the third quarter, we again delivered consolidated revenues and adjusted EBITDA in the upper half of our guidance ranges, reflecting consistent execution along with our steadfast commitment to...
Read More

Get in touch today

Contact Teladoc Health Investor Relations

Michael Minchak | Vice President, Investor Relations | IR@teladochealth.com